Förster resonance energy transfer competitive displacement assay for human soluble epoxide hydrolase

Kin Sing Stephen Lee, Christophe Morisseau, Jun Yang, Peng Wang, Sung Hee Hwang, Bruce D. Hammock

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The soluble epoxide hydrolase (sEH), responsible for the hydrolysis of various fatty acid epoxides to their corresponding 1,2-diols, is becoming an attractive pharmaceutical target. These fatty acid epoxides, particularly epoxyeicosatrienoic acids (EETs), play an important role in human homeostatic and inflammation processes. Therefore, inhibition of human sEH, which stabilizes EETs in vivo, brings several beneficial effects to human health. Although there are several catalytic assays available to determine the potency of sEH inhibitors, measuring the in vitro inhibition constant (Ki) for these inhibitors using catalytic assay is laborious. In addition, koff, which has been recently suggested to correlate better with the in vivo potency of inhibitors, has never been measured for sEH inhibitors. To better measure the potency of sEH inhibitors, a reporting ligand, 1-(adamantan-1-yl)-3-(1-(2-(7- hydroxy-2-oxo-2H-chromen-4-yl)acetyl) piperidin-4-yl)urea (ACPU), was designed and synthesized. With ACPU, we have developed a Förster resonance energy transfer (FRET)-based competitive displacement assay using intrinsic tryptophan fluorescence from sEH. In addition, the resulting assay allows us to measure the Ki values of very potent compounds to the picomolar level and to obtain relative koff values of the inhibitors. This assay provides additional data to evaluate the potency of sEH inhibitors.

Original languageEnglish (US)
Pages (from-to)259-268
Number of pages10
JournalAnalytical Biochemistry
Volume434
Issue number2
DOIs
StatePublished - Mar 15 2013

Fingerprint

Epoxide Hydrolases
Energy Transfer
Energy transfer
Assays
Epoxy Compounds
Fatty Acids
Acids
Tryptophan
Hydrolysis
Fluorescence
Health
Ligands
Inflammation
Pharmaceutical Preparations

Keywords

  • Binding assay
  • Competitive displacement assay
  • Fluorescent assay
  • Förster resonance energy transfer (FRET)
  • Soluble epoxide hydrolase

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology
  • Cell Biology

Cite this

Lee, K. S. S., Morisseau, C., Yang, J., Wang, P., Hwang, S. H., & Hammock, B. D. (2013). Förster resonance energy transfer competitive displacement assay for human soluble epoxide hydrolase. Analytical Biochemistry, 434(2), 259-268. https://doi.org/10.1016/j.ab.2012.11.015

Förster resonance energy transfer competitive displacement assay for human soluble epoxide hydrolase. / Lee, Kin Sing Stephen; Morisseau, Christophe; Yang, Jun; Wang, Peng; Hwang, Sung Hee; Hammock, Bruce D.

In: Analytical Biochemistry, Vol. 434, No. 2, 15.03.2013, p. 259-268.

Research output: Contribution to journalArticle

Lee, Kin Sing Stephen ; Morisseau, Christophe ; Yang, Jun ; Wang, Peng ; Hwang, Sung Hee ; Hammock, Bruce D. / Förster resonance energy transfer competitive displacement assay for human soluble epoxide hydrolase. In: Analytical Biochemistry. 2013 ; Vol. 434, No. 2. pp. 259-268.
@article{9487e82aad39478a837ebb9d31096dc7,
title = "F{\"o}rster resonance energy transfer competitive displacement assay for human soluble epoxide hydrolase",
abstract = "The soluble epoxide hydrolase (sEH), responsible for the hydrolysis of various fatty acid epoxides to their corresponding 1,2-diols, is becoming an attractive pharmaceutical target. These fatty acid epoxides, particularly epoxyeicosatrienoic acids (EETs), play an important role in human homeostatic and inflammation processes. Therefore, inhibition of human sEH, which stabilizes EETs in vivo, brings several beneficial effects to human health. Although there are several catalytic assays available to determine the potency of sEH inhibitors, measuring the in vitro inhibition constant (Ki) for these inhibitors using catalytic assay is laborious. In addition, koff, which has been recently suggested to correlate better with the in vivo potency of inhibitors, has never been measured for sEH inhibitors. To better measure the potency of sEH inhibitors, a reporting ligand, 1-(adamantan-1-yl)-3-(1-(2-(7- hydroxy-2-oxo-2H-chromen-4-yl)acetyl) piperidin-4-yl)urea (ACPU), was designed and synthesized. With ACPU, we have developed a F{\"o}rster resonance energy transfer (FRET)-based competitive displacement assay using intrinsic tryptophan fluorescence from sEH. In addition, the resulting assay allows us to measure the Ki values of very potent compounds to the picomolar level and to obtain relative koff values of the inhibitors. This assay provides additional data to evaluate the potency of sEH inhibitors.",
keywords = "Binding assay, Competitive displacement assay, Fluorescent assay, F{\"o}rster resonance energy transfer (FRET), Soluble epoxide hydrolase",
author = "Lee, {Kin Sing Stephen} and Christophe Morisseau and Jun Yang and Peng Wang and Hwang, {Sung Hee} and Hammock, {Bruce D.}",
year = "2013",
month = "3",
day = "15",
doi = "10.1016/j.ab.2012.11.015",
language = "English (US)",
volume = "434",
pages = "259--268",
journal = "Analytical Biochemistry",
issn = "0003-2697",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Förster resonance energy transfer competitive displacement assay for human soluble epoxide hydrolase

AU - Lee, Kin Sing Stephen

AU - Morisseau, Christophe

AU - Yang, Jun

AU - Wang, Peng

AU - Hwang, Sung Hee

AU - Hammock, Bruce D.

PY - 2013/3/15

Y1 - 2013/3/15

N2 - The soluble epoxide hydrolase (sEH), responsible for the hydrolysis of various fatty acid epoxides to their corresponding 1,2-diols, is becoming an attractive pharmaceutical target. These fatty acid epoxides, particularly epoxyeicosatrienoic acids (EETs), play an important role in human homeostatic and inflammation processes. Therefore, inhibition of human sEH, which stabilizes EETs in vivo, brings several beneficial effects to human health. Although there are several catalytic assays available to determine the potency of sEH inhibitors, measuring the in vitro inhibition constant (Ki) for these inhibitors using catalytic assay is laborious. In addition, koff, which has been recently suggested to correlate better with the in vivo potency of inhibitors, has never been measured for sEH inhibitors. To better measure the potency of sEH inhibitors, a reporting ligand, 1-(adamantan-1-yl)-3-(1-(2-(7- hydroxy-2-oxo-2H-chromen-4-yl)acetyl) piperidin-4-yl)urea (ACPU), was designed and synthesized. With ACPU, we have developed a Förster resonance energy transfer (FRET)-based competitive displacement assay using intrinsic tryptophan fluorescence from sEH. In addition, the resulting assay allows us to measure the Ki values of very potent compounds to the picomolar level and to obtain relative koff values of the inhibitors. This assay provides additional data to evaluate the potency of sEH inhibitors.

AB - The soluble epoxide hydrolase (sEH), responsible for the hydrolysis of various fatty acid epoxides to their corresponding 1,2-diols, is becoming an attractive pharmaceutical target. These fatty acid epoxides, particularly epoxyeicosatrienoic acids (EETs), play an important role in human homeostatic and inflammation processes. Therefore, inhibition of human sEH, which stabilizes EETs in vivo, brings several beneficial effects to human health. Although there are several catalytic assays available to determine the potency of sEH inhibitors, measuring the in vitro inhibition constant (Ki) for these inhibitors using catalytic assay is laborious. In addition, koff, which has been recently suggested to correlate better with the in vivo potency of inhibitors, has never been measured for sEH inhibitors. To better measure the potency of sEH inhibitors, a reporting ligand, 1-(adamantan-1-yl)-3-(1-(2-(7- hydroxy-2-oxo-2H-chromen-4-yl)acetyl) piperidin-4-yl)urea (ACPU), was designed and synthesized. With ACPU, we have developed a Förster resonance energy transfer (FRET)-based competitive displacement assay using intrinsic tryptophan fluorescence from sEH. In addition, the resulting assay allows us to measure the Ki values of very potent compounds to the picomolar level and to obtain relative koff values of the inhibitors. This assay provides additional data to evaluate the potency of sEH inhibitors.

KW - Binding assay

KW - Competitive displacement assay

KW - Fluorescent assay

KW - Förster resonance energy transfer (FRET)

KW - Soluble epoxide hydrolase

UR - http://www.scopus.com/inward/record.url?scp=84873382054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873382054&partnerID=8YFLogxK

U2 - 10.1016/j.ab.2012.11.015

DO - 10.1016/j.ab.2012.11.015

M3 - Article

C2 - 23219719

AN - SCOPUS:84873382054

VL - 434

SP - 259

EP - 268

JO - Analytical Biochemistry

JF - Analytical Biochemistry

SN - 0003-2697

IS - 2

ER -